BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dean LT, Ransome Y, Frasso-Jaramillo L, Moss SL, Zhang Y, Ashing K, Denis GV, Frick KD, Visvanathan K, Schmitz KH. Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv 2019;13:804-14. [PMID: 31446591 DOI: 10.1007/s11764-019-00799-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data. J Cancer Surviv 2022. [DOI: 10.1007/s11764-022-01282-0] [Reference Citation Analysis]
2 Salehi BP, Sibley RC, Friedman R, Kim G, Singhal D, Loening AM, Tsai LL. MRI of Lymphedema. J Magn Reson Imaging 2022. [PMID: 36271779 DOI: 10.1002/jmri.28496] [Reference Citation Analysis]
3 Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 2022;195:33-41. [PMID: 35816269 DOI: 10.1007/s10549-022-06667-4] [Reference Citation Analysis]
4 Chen JC, Li Y, Fisher JL, Bhattacharyya O, Tsung A, Obeng-Gyasi S. Neighborhood socioeconomic status and low-value breast cancer care. J Surg Oncol 2022. [PMID: 35452136 DOI: 10.1002/jso.26901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Coughlin SS, Moore JX, Cortes JE. Addressing financial toxicity in oncology care. J Hosp Manag Health Policy 2021;5:32. [PMID: 34549166 DOI: 10.21037/jhmhp-20-68] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Cortina CS, Bergom C, Craft MA, Fields B, Brazauskas R, Currey A, Kong AL. A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients. Ann Surg Oncol 2021;28:5568-79. [PMID: 34247336 DOI: 10.1245/s10434-021-10441-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Cakir A, Tuncer M, Taymaz-Nikerel H, Ulucan O. Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection. Pharmacogenomics J 2021. [PMID: 34155353 DOI: 10.1038/s41397-021-00246-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kuijer A, Dominici LS, Rosenberg SM, Hu J, Gelber S, Di Lascio S, Wong JS, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Come SE, Sprunck-Harrild K, Partridge AH, King TA. Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol 2021. [PMID: 33881656 DOI: 10.1245/s10434-021-09947-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Arikan Dönmez A, Kuru Alici N, Borman P. Lived Experiences for Supportive Care Needs of Women with Breast Cancer-Related Lymphedema: A Phenomenological Study. Clin Nurs Res 2021;30:799-808. [PMID: 32955348 DOI: 10.1177/1054773820958115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Coughlin SS, Ayyala DN, Tingen MS, Cortes JE. Financial distress among breast cancer survivors. Curr Cancer Rep 2020;2:48-53. [PMID: 32984842 DOI: 10.25082/CCR.2020.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rustad KC, Chang DW. Surgical Approaches to the Prevention and Management of Breast Cancer–Related Lymphedema. Curr Breast Cancer Rep 2020;12:185-92. [DOI: 10.1007/s12609-020-00372-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Dean LT, George M, Lee KT, Ashing K. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence. Cancer 2020;126:3606-12. [PMID: 32438466 DOI: 10.1002/cncr.32946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
13 Lauzon SD, Ramakrishnan V, Nietert PJ, Ciolino JD, Hill MD, Zhao W. Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials. Stat Med 2020;39:2506-17. [PMID: 32363614 DOI: 10.1002/sim.8552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]